journal
MENU ▼
Read by QxMD icon Read
search

European Journal of Nuclear Medicine and Molecular Imaging

journal
https://read.qxmd.com/read/30879123/grade-3-anaphylactic-shock-after-administration-of-99m-tc-labeled-nanocolloidal-albumin-nanocoll-%C3%A2-for-sentinel-node-scintigraphy
#1
LETTER
Andrea Skanjeti, Caroline Darcissac, Coline Jaulent, Jérôme Nicolas, François Hallouard, Isabelle Morelec, Marc Fraysse, Jérémie Tordo, Francesco Giammarile, Pierre-Adrien Bolze, Anthony Dhomps
No abstract text is available yet for this article.
March 16, 2019: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/30879122/prospective-comparison-of-whole-body-mri-and-68-ga-psma-pet-ct-for-the-detection-of-biochemical-recurrence-of-prostate-cancer-after-radical-prostatectomy
#2
Lino M Sawicki, Julian Kirchner, Carolin Buddensieck, Christina Antke, Tim Ullrich, Lars Schimmöller, Johannes Boos, Christoph Schleich, Benedikt M Schaarschmidt, Christian Buchbender, Philipp Heusch, Robert Rabenalt, Peter Albers, Gerald Antoch, Hans-Wilhelm Müller, Hubertus Hautzel
PURPOSE: To assess whole-body magnetic resonance imaging (wb-MRI) for detection of biochemical recurrence in comparison to 68 Ga-prostate-specific membrane antigen positron emission tomography/computed tomography (68 Ga-PSMA PET/CT) in prostate cancer (Pca) patients after radical prostatectomy. METHODS: This was a prospective trial including 28 consecutive patients (mean age 65.3 ± 9.0 years) with newly documented biochemical recurrence of Pca (mean prostate-specific antigen, PSA, 2...
March 16, 2019: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/30874857/-68-ga-dotanoc-and-18-f-dopa-pet-ct-a-site-specific-approach-to-the-imaging-of-parangliomas-of-the-head-and-neck-and-of-the-abdomen
#3
Diletta Calabrò, Vincenzo Allegri, Stefano Fanti, Valentina Ambrosini
No abstract text is available yet for this article.
March 14, 2019: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/30868230/radiotherapy-boost-in-patients-with-hypoxic-lesions-identified-by-18-f-fmiso-pet-ct-in-non-small-cell-lung-carcinoma-can-we-expect-a-better-survival-outcome-without-toxicity-rtep5-long-term-follow-up
#4
Pierre Vera, Sorina-Dana Mihailescu, Justine Lequesne, Romain Modzelewski, Pierre Bohn, Sébastien Hapdey, Louis-Ferdinand Pépin, Bernard Dubray, Philippe Chaumet-Riffaud, Pierre Decazes, Sébastien Thureau
PURPOSE: Chemoradiotherapy is the reference curative-intent treatment for nonresectable locally advanced non-small-cell lung carcinoma (NSCLC), with unsatisfactory survival, partially due to radiation resistance in hypoxic tissues. The objective was to update survival and toxicity at 3 years following radiotherapy boost to hypoxic tumours in NSCLC patients treated with curative-intent chemoradiotherapy. METHODS: This was an open-label, nonrandomized, multicentre, phase II clinical trial...
March 13, 2019: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/30868228/small-voxel-reconstructions-significantly-influence-suvs-in-pet-imaging
#5
LETTER
Daniëlle Koopman, Pieter L Jager, Jorn A van Dalen
No abstract text is available yet for this article.
March 13, 2019: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/30863934/is-there-a-difference-in-regional-read-18-f-flutemetamol-amyloid-patterns-between-end-of-life-subjects-and-those-with-amnestic-mild-cognitive-impairment
#6
Gill Farrar, José Luis Molinuevo, Michelle Zanette
PURPOSE: Visual interpretation of PET [18 F]flutemetamol images relies on systematic review of five brain regions and is considered positive when an elevated signal is observed in at least one region. Amnestic mild cognitive impairment (aMCI) is an early clinical presentation of Alzheimer's disease (AD); hence it is of interest to determine if the pattern of visually read regional positivity between end-of-life (EoL) patients with and without dementia and aMCI patients is different. METHODS: A total of 180 EoL patients with and without dementia (mean age 81 years, range 59 to 95 years) and 232 aMCI patients (mean age 71 years, range 53 to 91 years) were scanned following intravenous administration of 185-370 MBq [18 F]flutemetamol...
March 13, 2019: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/30868229/one-stop-shopping-18-f-fdg-pet-ct-in-a-patient-with-vascular-type-beh%C3%A3-et-s-disease
#7
Takashi Norikane, Yuka Yamamoto, Yasukage Takami, Katsuya Mitamura, Hanae Arai-Okuda, Yoshihiro Nishiyama
No abstract text is available yet for this article.
March 12, 2019: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/30863933/18f-flurodeoxyglucose-positron-emission-tomography-with-computed-tomography-fdg-pet-ct-findings-in-children-with-encephalitis-and-comparison-to-conventional-imaging
#8
Sophie Turpin, Patrick Martineau, Marc-André Levasseur, Inge Meijer, Jean-Claude Décarie, Julie Barsalou, Christian Renaud, Hélène Decaluwe, Elie Haddad, Raymond Lambert
PURPOSE: FDG PET/CT is emerging as a new tool for the evaluation of acute encephalitis (AE). However, to date, there are no exclusively pediatric studies on the use of FDG PET for suspected AE. The objective of this study was to compare qualitative and quantitative brain PET to conventional brain imaging in a cohort of children, and to identify patterns of metabolic abnormalities characteristic of AE. METHODS: This retrospective study included 34 children imaged with PET/CT, CT and magnetic resonance imaging (MRI)...
March 12, 2019: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/30859432/tsh-suppression-aggravates-arterial-inflammation-an-18-f-fdg-pet-study-in-thyroid-carcinoma-patients
#9
Ellen Boswijk, Karin J C Sanders, Evie P M Broeders, Marlies de Ligt, Guy H E J Vijgen, Bas Havekes, Alma M A Mingels, Roel Wierts, Wouter D van Marken Lichtenbelt, Patrick Schrauwen, Felix M Mottaghy, Joachim E Wildberger, Jan Bucerius
PURPOSE: We aimed to investigate the influence of both hypothyroidism and thyroid-stimulating hormone (TSH) suppression on vascular inflammation, as assessed with 18 F-fluorodeoxyglucose (18 F-FDG) positron emission tomography (PET)/computed tomography (CT). METHODS: Ten thyroid carcinoma patients underwent an 18 F-FDG PET/CT during post-thyroidectomy hypothyroidism and during thyrotropin (TSH) suppression after 131 I (radioiodine) ablation therapy. We analysed the 18 F-FDG uptake in the carotids, aortic arch, ascending, descending, and abdominal aorta to investigate the effects of thyroid hormone status on arterial inflammation...
March 11, 2019: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/30859431/digital-pet-ct-a-new-intriguing-chance-for-clinical-nuclear-medicine-and-personalized-molecular-imaging
#10
EDITORIAL
Orazio Schillaci, Nicoletta Urbano
No abstract text is available yet for this article.
March 11, 2019: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/30850872/-18-f-fpprgd-2-pet-ct-in-patients-with-metastatic-renal-cell-cancer
#11
Akira Toriihara, Heying Duan, Holly M Thompson, Sonya Park, Negin Hatami, Lucia Baratto, Alice C Fan, Andrei Iagaru
PURPOSE: The usefulness of positron emission tomography/computed tomography (PET/CT) using (18 F)-2-fluoropropionyl-labeled PEGylated dimeric arginine-glycine-aspartic acid peptide [PEG3-E{c(RGDyk)}2] (18 F-FPPRGD2 ) in patients with metastatic renal cell cancer (mRCC) has not been evaluated; therefore, we were prompted to conduct this pilot study. METHODS: Seven patients with mRCC were enrolled in this prospective study. 18 F-FPPRGD2 and 2-deoxy-2-(18 F)fluoro-D-glucose (18 F-FDG) PET/CT images were evaluated in a per-lesion analysis...
March 8, 2019: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/30848328/-18-f-fdg-uptake-of-brown-fat-and-cancer-casualty-or-causality
#12
LETTER
Nicolò Gennaro, Giovanna Pepe, Lidija Antunovic
No abstract text is available yet for this article.
March 8, 2019: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/30847538/clinical-utility-of-68-ga-dotatoc-positron-emission-tomography-computed-tomography-for-recurrent-renal-cell-carcinoma
#13
Yuji Nakamoto, Takayoshi Ishimori, Yoichi Shimizu, Kohei Sano, Kaori Togashi
PURPOSE: Positron emission tomography (PET)/computed tomography (CT) with 68 Ga-labelled 1,4,7,10-tetraazacyclododecane-N,N',N″,N″'-tetraacetic acid-D-Phe1 -Tyr3 -octreotide (DOTATOC) has been accepted as a diagnostic imaging tool especially for patients with neuroendocrine tumours. However, its clinical usefulness for restaging of renal cell carcinoma (RCC) has not been fully investigated. This retrospective study was performed to elucidate the clinical value of PET/CT using 68 Ga-DOTATOC in patients with known or suspected recurrent RCC...
March 7, 2019: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/30838430/dosimetry-based-high-activity-therapy-with-131-i-metaiodobenzylguanidine-131-i-mibg-and-topotecan-for-the-treatment-of-high-risk-refractory-neuroblastoma
#14
Jose Genolla, Trinidad Rodriguez, Pablo Minguez, Ricardo Lopez-Almaraz, Veronica Llorens, Aizpea Echebarria
PURPOSE: Patients with high-risk neuroblastoma have an increased risk of recurrence and relapse of disease and a very poor prognosis. 131 I-metaiodobenzylguanidine (131 I-mIBG) in combination with topotecan as a radiosensitizer can be an effective and relatively well-tolerated agent for the treatment of refractory neuroblastoma. The aim of this retrospective study was to evaluate response and outcome of combined therapy with 131 I-mIBG and topotecan. METHODS: Ten patients, between 3 and 20 years of age, were included...
March 5, 2019: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/30826897/in-response-to-the-validity-of-18-f-ge180-as-a-tspo-imaging-agent
#15
LETTER
Nathalie L Albert, Marcus Unterrainer, Matthias Brendel, Lena Kaiser, Markus Zweckstetter, Paul Cumming, Peter Bartenstein
No abstract text is available yet for this article.
March 2, 2019: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/30824964/comment-on-relationship-between-the-expression-of-pd-1-pd-l1-and-18-f-fdg-uptake-in-bladder-cancer
#16
LETTER
Antoine Girard, Mathieu Rouanne
No abstract text is available yet for this article.
March 1, 2019: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/30806751/baseline-pet-features-to-predict-prognosis-in-primary-mediastinal-b-cell-lymphoma-a-comparative-analysis-of-different-methods-for-measuring-baseline-metabolic-tumour-volume
#17
Luca Ceriani, Lisa Milan, Peter W M Johnson, Maurizio Martelli, Stefano Presilla, Luca Giovanella, Emanuele Zucca
PURPOSE: This study assessed the performance of four different methods for the estimation of metabolic tumour volume (MTV) in primary mediastinal B cell lymphoma (PMBCL). METHOD: MTV was estimated using either a region growing automatic software program (RG) or a fixed threshold (FT) segmentation algorithm with the three most common cut-offs proposed in the literature (i.e., 25% and 41% of the SUVmax and SUV value ≥2.5). We compared these four methods using phantoms that simulated different set-ups of the main imaging characteristics of PMBCL (volume, shape, 18-FDG uptake and intra-lesion distribution) and assessed their performance in 103 PMBCL patients enrolled in the International Extranodal Lymphoma Study Group-26 (IELSG-26) study...
February 26, 2019: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/30806750/the-impact-of-revascularization-on-myocardial-blood-flow-as-assessed-by-positron-emission-tomography
#18
Robert M Bober, Richard V Milani, Ahmet A Oktay, Fahad Javed, Nichole M Polin, Daniel P Morin
PURPOSE: Revascularization aims to improve myocardial perfusion. However, changes in regional artery-specific quantitative perfusion after revascularization have not been systematically investigated. It is unclear whether artery-specific thresholds for coronary flow capacity (CFC) and/or relative perfusion predict improved stress perfusion after revascularization. We sought to determine the impact of revascularization based on predefined, artery-specific, severity size thresholds for CFC and/or relative perfusion defects...
February 26, 2019: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/30806749/is-the-effect-of-hyperglycemia-on-liver-18-f-fdg-standardized-uptake-value-really-clinically-significant
#19
LETTER
Stephan Altmayer, Matheus Zanon, Clarice Sprinz, Guilherme Watte, Bruno Hochhegger
No abstract text is available yet for this article.
February 26, 2019: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/30798428/perioperative-pet-ct-lymphoscintigraphy-and-fluorescent-real-time-imaging-for-sentinel-lymph-node-mapping-in-early-staged-colon-cancer
#20
M Ankersmit, O S Hoekstra, A van Lingen, E Bloemena, M A J M Jacobs, D J Vugts, H J Bonjer, G A M S van Dongen, W J H J Meijerink
PURPOSE: Using current optical imaging techniques and gamma imaging modalities, perioperative sentinel lymph node (SLN) identification in colon cancer can be difficult when the SLN is located near the primary tumour or beneath a thick layer of (fat) tissue. Sentinel lymph node mapping using PET/CT lymphoscintigraphy combined with real-time visualization of the SLN using near-infrared imaging has shown promising results in several types of cancer and may facilitate the successful identification of the number and location of the SLN in early colon cancer...
February 23, 2019: European Journal of Nuclear Medicine and Molecular Imaging
journal
journal
20104
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"